BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Lumena Pharmaceuticals Receives Orphan Drug Designation From FDA for LUM001 in Four Rare Liver Diseases

  September 26, 2013

   · 

  5 min read
• Business

  Allergan Inc. to Pay Medy-Tox Inc. $65 Million Upfront for Rights to Certain Products

  September 26, 2013

   · 

  4 min read
• Drug Development

  Novo Nordisk A/S Study Shows Tresiba Efficacy for Diabetes

  September 26, 2013

   · 

  1 min read
• Drug Development

  Chimerix, Inc. Reports Positive Phase 2 Results of Brincidofovir (CMX001)

  September 26, 2013

   · 

  8 min read
• Policy

  Integra LifeSciences Holdings Corporation Resolves Violations at New Jersey Manufacturing Facility

  September 26, 2013

   · 

  1 min read
• BioMidwest

  Elorac, Inc. Receives Notice of Allowance From U.S. Patent Office for Novel Acne Therapy

  September 26, 2013

   · 

  1 min read
• Andor iXon 897 EMCCD Camera Images 4 Bose-Einstein Condensates Simultaneously

  September 26, 2013

   · 

  3 min read
• Business

  Transcept Pharmaceuticals, Inc. and Shin Nippon Biomedical Laboratories Announce Global Licensing Agreement for Advanced Acute Migraine Treatment

  September 26, 2013

   · 

  10 min read
• Business

  Ipsen to Relocate U.S. R&D Activities to Cambridge, Massachusetts in 2014

  September 26, 2013

   · 

  6 min read
• Biotech Beach

  Lumena Pharmaceuticals Launches Global Clinical Program to Evaluate Safety and Efficacy of LUM001 in Children With Alagille Syndrome

  September 26, 2013

   · 

  5 min read